cagrisema vs retatrutide CagriSema: a novel dual-pathway approach to target obesity and its complications IMPORTANT: Next GLP-1 Coming! RETATRUTIDE

Genetic and Dermatological Observations Variants in MC1R genes have been associated with variable pigmentation responses in laboratory settings

Consistency matters more than quantity

Generally speaking: Initial antioxidant benefits may begin within 24 weeks Skin brightness improvements may appear within 612 weeks More visible changes often develop over 36 months The body first prioritizes essential functions like detoxification and cellular repair

found that GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) significantly increased total testosterone and improved gonadotropin levels, especially in obese men